| Literature DB >> 35927412 |
Eman Yosrey1, Heba Elmansi2, Zeinab A Sheribah2, Mohammed El-Sayed Metwally2.
Abstract
Hydrophilic interaction liquid chromatography (HILIC) has inherent merits over RP-HPLC in the analyzing of hydrophilic substances. Accordingly, an innovative HILIC-UV methodology is proposed for the simultaneous estimation of ethyl paraben (PRN), fluconazole (FLZ) and moxifloxacin hydrochloride (MOX) in raw materials and pharmaceutical eye gel. The separation process was conducted using Waters XBridge™ HILIC column (100 mm × 4.6 mm, 3.5 μm particle size) at room temperature. Isocratic mobile phase containing acetonitrile: 0.1% triethylamine buffer (90:10, v/v, pH 5.0), was pumped at flow rate 1.0 mL/min and detected at 260 nm. Under these optimized conditions, PRN, FLZ and MOX showed rectilinear relationships with the concentration ranges (0.5-6.0), (5.0-50.0) and (5.0-60.0) μg/mL, respectively. The developed method offered at least fivefold increase in sensitivity within shorter time than the reported methods. Three greenness assessment tools namely: Analytical eco-scale, GAPI and AGREE were exploited to investigate the method's impact on the environment and conduct a comparative study with the reported methods. International council of Harmonization (ICH) guidelines have been followed to calculate validation parameters. The statistical comparison between results of the suggested method and the comparison method showed no discrepancy confirming accuracy of the method.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35927412 PMCID: PMC9352657 DOI: 10.1038/s41598-022-17064-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Structural formulae of: (a) FLZ. (b) MOX. (c) PRN.
Figure 2Typical chromatogram of laboratory prepared mixture of the studied components under the described chromatographic conditions. (a) PRN (0.5 μg/mL), (b) FLZ (5.0 μg/mL) and (c) MOX (5.0 μg/mL).
The optimum chromatographic parameters obtained for separation of the studied drugs by the proposed HILIC method.
| Compound | Number of theoretical plates (NTP) | Tailing factor (T | Resolution (RS) |
|---|---|---|---|
| PRN | 2079.883 | 1.341 | |
| FLZ | 2289.228 | 1.575 | (PRN/FLZ) = 2.529 |
| MOX | 4818.775 | 1.493 | (FLZ/MOX) = 11.102 |
Figure 3UV spectrum of: (a) PRN (5.0 μg/mL), (b) FLZ (20.0 μg/mL) and (c) MOX (5.0 μg/mL).
Analytical performance data for the determination of the studied drugs by the proposed HILIC method.
| Parameter | PRN | FLZ | MOX |
|---|---|---|---|
| Concentration range (µg/mL) | 0.5–6.0 | 5.0–50.0 | 5.0–60.0 |
| LOD (µg/mL) | 0.14 | 0.94 | 1.38 |
| LOQ (µg/mL) | 0.42 | 2.84 | 4.19 |
| Correlation coefficient (r) | 0.9998 | 0.9998 | 0.9998 |
| Slope ( | 45,810.35 | 1027.48 | 46,485.46 |
| Intercept ( | 82,811.37 | 7726.65 | 72,895.06 |
| Sy/x* | 2480.63 | 373.06 | 22,587.12 |
| Sa* | 1944.13 | 292.15 | 19,486.93 |
| Sb* | 515.01 | 10.43 | 502.45 |
| %Error* | 0.48 | 0.64 | 0.50 |
| %RSD | 1.08 | 1.44 | 1.21 |
| No. of experiments | 5 | 5 | 6 |
| Mean found (%) ± SD | 99.91 ± 1.07 | 99.87 ± 1.44 | 99.90 ± 1.21 |
*N.B.
Sy/x = standard deviation of the residuals.
Sa = standard deviation of the intercept of regression line.
Sb = standard deviation of the slope of regression line.
% Error = RSD%/√ n.
Application of the proposed method and the comparison method for the analysis of the studied drugs in raw materials.
| Parameters | Proposed method | Comparison method[ | |||
|---|---|---|---|---|---|
| Amount taken (μg/mL) | Amount found (μg/mL) | Found (%) | Amount taken (μg/mL) | Found (%) | |
| PRN | 0.5 | 0.498 | 99.60 | 2.0 | 99.50 |
| 1.0 | 0.988 | 98.80 | 3.0 | 100.37 | |
| 3.0 | 3.051 | 101.70 | 5.0 | 99.94 | |
| 5.0 | 4.982 | 99.64 | |||
| 6.0 | 5.989 | 99.82 | |||
| X− ± SD | 99.91 ± 1.07 | 99.94 ± 0.44 | |||
| Student' | 0.04 (2.45)* | ||||
| Variance ratio (F test) | 6.10 (19.25)* | ||||
| FLZ | 5.0 | 4.895 | 97.90 | 20.0 | 98.23 |
| 10.0 | 10.050 | 100.50 | 30.0 | 101.12 | |
| 20.0 | 20.347 | 101.74 | 50.0 | 99.83 | |
| 30.0 | 29.759 | 99.20 | |||
| 50.0 | 49.998 | 100.00 | |||
| X− ± SD | 99.87 ± 1.44 | 99.73 ± 1.45 | |||
| Student's t-test | 0.13 (2.45)* | ||||
| Variance ratio (F test) | 1.02 (6.944)* | ||||
| MOX | 5.0 | 4.935 | 98.70 | 20.0 | 98.02 |
| 20.0 | 20.228 | 101.14 | 30.0 | 101.90 | |
| 30.0 | 30.117 | 100.39 | 50.0 | 99.63 | |
| 40.0 | 39.302 | 98.26 | |||
| 50.0 | 50.548 | 101.10 | |||
| 60.0 | 59.879 | 99.80 | |||
| X− ± SD | 99.90 ± 1.21 | 99.85 ± 1.95 | |||
| Student's t-test | 0.05 (2.36)* | ||||
| Variance ratio (F test) | 2.58 (5.786)* | ||||
*Values between parentheses are the tabulated t and F values[31].
Assay results for the determination of the studied drugs in laboratory-prepared gel.
| Parameters | Proposed method | Comparison method[ | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Amount taken (μg/mL) | Amount taken (μg/mL) | Amount taken (μg/mL) | Found (%) | Found (%) | Found (%) | Found (%) | Found (%) | Found (%) | |
| PRN/FLZ/MOX | 2.0 | 20.0 | 20.0 | 101.30 | 98.51 | 99.53 | 99.20 | 98.56 | 99.51 |
| 3.0 | 30.0 | 30.0 | 100.68 | 99.46 | 99.33 | 99.50 | 100.09 | 99.20 | |
| 5.0 | 50.0 | 50.0 | 98.77 | 99.98 | 100.26 | 99.95 | 99.57 | 98.42 | |
| X− ± SD | 100.25 ± 1.32 | 99.32 ± 0.62 | 99.71 ± 0.49 | 99.55 ± 0.38 | 99.41 ± 0.78 | 99.04 ± 0.56 | |||
| Student's t-test | 0.88 (2.78)* | 0.14 (2.78)* | 1.54 (2.78)* | ||||||
| Variance ratio (F test) | 12.20 (19.00)* | 1.09 (19.00)* | 1.32 (19.00)* | ||||||
*Values between parentheses are the tabulated t and F values[31].
Figure 4Greenness evaluation by AGREE and GABI, where (a) Evaluation for the reported HPLC method[3]. (b) Evaluation for the reported HPLC method[22]. (c) Evaluation for the suggested HILIC method.